查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1963976

下一代成像技术市场－全球产业规模、份额、趋势、机会、预测：按技术、应用、类型、地区和竞争格局划分，2021-2031年

Next Imaging Technology Market - Global Industry Size, Share, Trends, Opportunity, and Forecast Segmented By Technique, By Application, By Type, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

全球新一代成像技术市场预计将从 2025 年的 69.9 亿美元成长到 2031 年的 129.5 亿美元，复合年增长率达到 10.83%。

下一代成像技术涵盖了超越传统二维成像限制的先进视觉化系统，包括四维成像、高光谱遥测和全像显示等多种模式，并已应用于医疗和工业领域。推动该市场发展的关键因素包括医疗领域对精准早期诊断能力的日益增长的需求，以及製造业对自动化、零缺陷品质保证的日益增长的需求。此外，人们对非侵入性医疗干预的偏好不断增强，也加速了这些高清成像解决方案的普及，与传统设备相比，这些解决方案具有许多操作优势。

市场概览
预测期 2027-2031
市场规模：2025年 69.9亿美元
市场规模：2031年 129.5亿美元
复合年增长率：2026-2031年 10.83%
成长最快的细分市场 CMOS影像
最大的市场 北美洲

儘管有这些有利条件，市场仍面临一个重大障碍：这些先进技术需要大量的资本投资，而全球经济的不确定性加剧了这个挑战。这种财务压力可能会减缓技术的普及速度，因为企业会优先考虑必要的维护，而不是升级到高阶系统。例如，德国机械设备製造业联合会（VDMA）机器人与自动化协会预测，到2025年，机器视觉领域的收入将达到31亿欧元，这一数字反映了由于投资计画延迟而导致的停滞和零成长时期。这些经济逆风凸显了在谨慎的投资环境下，终端用户难以证明采用下一代影像技术所带来的高成本是合理的。

市场驱动因素

人工智慧 (AI) 和机器学习 (ML) 与诊断影像技术的融合是推动全球下一代成像技术市场发展的主要动力。这些计算技术将标准视觉化转化为预测分析，从而实现自动异常检测和即时影像重建。透过将演算法整合到磁振造影 (MRI) 和电脑断层扫描 (CT) 等影像方式中，製造商正在帮助临床医生更快、更准确地解读复杂的 3D 和 4D 数据，显着降低诊断错误率。监管方面的里程碑事件也印证了演算法辅助方法在临床实践中的安全性和有效性，进一步推动了这项技术整合。特别是，美国食品药物管理局(FDA) 于 2024 年 5 月宣布已核准882 款搭载 AI/ML 技术的医疗设备，凸显了智慧诊断工具的快速商业化进程。

同时，全球慢性病盛行率的不断上升和人口老化凸显了高解析度早期检测系统的必要性。随着患者群体的变化，医疗机构正优先采用精准医疗工具，以便早期识别肿瘤和心血管疾病等病症。这些人口结构压力迫使医院转型升级，采用能够进行体积和高光谱遥测的数位基础设施，从而高效应对日益增长的患者数量。根据美国癌症协会于2024年1月发布的《2024年癌症事实与数据》报告，预计仅2024年美国就将新增2,001,140例癌症病例，凸显了先进筛检技术的重要性。因此，主要产业参与者正从先进诊断领域获得丰厚的利润；Olympus Corporation公布，截至2024年3月31日的财年，其内视镜解决方案业务的收入为6026亿日圆。

市场挑战

下一代影像系统所需的巨额资本投入是市场扩张的一大障碍。高光谱遥测和4D成像等先进技术价格高昂，且需要大规模支出，这在经济波动时期对许多企业来说难以承受。随着企业预算的缩减，核准通常会优先考虑日常营运维护，而不是购置高成本、无缺陷的视觉化工具，这导致销售週期延长，部署策略也随之延迟。

这种财务上的犹豫与整个自动化产业的市场萎缩直接相关。正如德国机械设备製造业联合会（VDMA）在2025年6月发布的《机器人与自动化》报告所述，由于投资计画的延迟和地缘政治紧张局势，预计德国自动化产业整体年收入将下降10%。这项统计数据表明，经济的不确定性迫使终端用户冻结资本支出，从而抑制了先进成像技术的发展势头，儘管这些技术具有技术优势。因此，无法证明这些高成本投资能够即时获得回报，仍是市场渗透的主要障碍。

市场趋势

向永续的无氦磁振造影（MRI）架构转型正在重塑市场格局，其关键在于解决依赖液态氦带来的供应链脆弱性。传统扫描器需要数千公升冷却剂，这使得供应商面临商品价格波动和冷却剂洩漏（冷却剂洩漏）的风险，而后者需要昂贵的排气基础设施。透过采用密封式低氦磁铁技术，医疗机构可以消除这些物流负担，同时由于系统重量减轻，还能在以前无法安装的位置进行安装。飞利浦在2024年11月的新闻稿中进一步强调了业界向营运稳健型基础设施的转变，该公司表示，其下一代无氦MRI系统BlueSeal迄今已节省了约275万公升液氦。

光子计数CT系统的商业化标誌着硬体从基于闪烁体的检测器向直接转换感测器的演进。这种架构透过探测单一X射线光子提供独特的频谱数据，显着降低电子噪声，并实现精细结构的清晰成像。与传统的能量积分检测器不同，这些平台能够实现精确的材料分辨率，并降低易感患者群体的辐射暴露。为了强调这项先进技术在临床上的应用，西门子健康保险公司在2024年12月的新闻稿中宣布扩展其光子计数CT产品组合，并确认全球已有超过一百万名患者接受了使用该公司光子计数技术的扫描。

目录

第一章概述

第二章：调查方法

第三章执行摘要

第四章：客户心声

第五章：下一代成像技术的全球市场展望

  • 市场规模及预测
    • 按金额
  • 市占率及预测
    • 透过技术（光学、射线照相、热成像、扫描）
    • 按应用领域（医疗、汽车、监控、土木工程）
    • 按类型（电磁成像、CMOS成像）
    • 按地区
    • 按公司（2025 年）
  • 市场地图

第六章：北美下一代成像技术市场展望

  • 市场规模及预测
  • 市占率及预测
  • 北美洲：国别分析
    • 我们
    • 加拿大
    • 墨西哥

第七章：欧洲下一代成像技术市场展望

  • 市场规模及预测
  • 市占率及预测
  • 欧洲：国别分析
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙

第八章：亚太地区下一代成像技术市场展望

  • 市场规模及预测
  • 市占率及预测
  • 亚太地区：国别分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲

第九章：中东和非洲下一代成像技术市场展望

  • 市场规模及预测
  • 市占率及预测
  • 中东与非洲：国别分析
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非

第十章：南美下一代成像技术市场展望

  • 市场规模及预测
  • 市占率及预测
  • 南美洲：国别分析
    • 巴西
    • 哥伦比亚
    • 阿根廷

第十一章 市场动态

  • 促进因素
  • 任务

第十二章 市场趋势与发展

  • 併购
  • 产品发布
  • 近期趋势

第十三章：全球下一代成像技术市场：SWOT分析

第十四章：波特五力分析

  • 产业竞争
  • 新进入者的潜力
  • 供应商的议价能力
  • 顾客权力
  • 替代品的威胁

第十五章 竞争格局

  • Siemens Healthineers AG
  • GE HealthCare Technologies Inc.
  • Philips Healthcare
  • Canon Medical Systems Corporation
  • Fujifilm Holdings Corporation
  • Sony Corporation
  • Qualcomm Technologies, Inc.
  • Olympus Corporation
  • Karl Storz SE & Co. KG
  • Nanox.vision Ltd.

第十六章 策略建议

第十七章：关于研究公司及免责声明

简介目录
Product Code: 22777

The Global Next Imaging Technology Market is projected to expand from a valuation of USD 6.99 Billion in 2025 to USD 12.95 Billion by 2031, achieving a Compound Annual Growth Rate (CAGR) of 10.83%. Next Imaging Technology encompasses sophisticated visualization systems that surpass traditional two-dimensional limits, including modalities such as four-dimensional imaging, hyperspectral analysis, and holographic displays utilized in both medical and industrial fields. The primary forces driving this market include the increasing need for precise, early diagnostic capabilities in healthcare and the rising demand for automated, zero-defect quality assurance in manufacturing. Additionally, the growing preference for non-invasive medical interventions accelerates the adoption of these high-fidelity imaging solutions, which offer operational advantages distinct from conventional legacy equipment.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 6.99 Billion
Market Size 2031USD 12.95 Billion
CAGR 2026-203110.83%
Fastest Growing SegmentCMOS Imaging
Largest MarketNorth America

Despite these positive drivers, the market faces a substantial obstacle due to the significant capital expenditure required for these advanced technologies, a challenge often intensified by global economic instability. This financial pressure can result in slower adoption rates as organizations prioritize essential maintenance over upgrading to premium systems. For instance, the VDMA Robotics + Automation association projected that the machine vision subsector would generate revenues of €3.1 billion in 2025, marking a period of stagnation and zero growth attributed to deferred investment plans. Such economic headwinds underscore the difficulty end-users face in justifying the high costs associated with deploying next-generation imaging during a cautious investment climate.

Market Driver

The incorporation of Artificial Intelligence and Machine Learning into imaging diagnostics acts as a primary engine for the advancement of the Global Next Imaging Technology Market. These computational technologies convert standard visualization into predictive analytics, facilitating automated anomaly detection and real-time image reconstruction. By embedding algorithms into modalities such as MRI and CT, manufacturers empower clinicians to interpret complex 3D and 4D data with greater speed and accuracy, significantly minimizing diagnostic errors. This technological convergence is supported by regulatory milestones confirming the safety and efficacy of algorithmic support in clinical settings; notably, the U.S. Food and Drug Administration reported in May 2024 that it had authorized 882 AI/ML-enabled medical devices, highlighting the rapid commercialization of intelligent diagnostic tools.

Simultaneously, the escalating global prevalence of chronic diseases and an aging population drive the necessity for high-resolution, early-detection systems. As patient demographics shift, healthcare providers are prioritizing precision medicine tools capable of identifying pathologies like oncology and cardiovascular conditions at their nascent stages. This demographic pressure compels hospitals to upgrade from analog to digital infrastructures capable of volumetric and hyperspectral analysis to efficiently manage high patient throughput. According to the American Cancer Society's 'Cancer Facts & Figures 2024' report from January 2024, the United States alone is expected to diagnose 2,001,140 new cancer cases in 2024, underscoring the critical need for advanced screening technologies. Consequently, major industry players are securing substantial financial returns from their advanced diagnostic divisions, with Olympus Corporation reporting revenue of ¥602.6 billion for its Endoscopic Solutions Business for the fiscal year ending March 31, 2024.

Market Challenge

The immense capital investment required for next-generation imaging systems constitutes a critical barrier to market expansion. Advanced modalities, such as hyperspectral analysis and four-dimensional imaging, command premium pricing, necessitating large-scale financial outlays that many organizations find difficult to authorize during periods of economic volatility. When corporate budgets contract, decision-makers typically prioritize operational maintenance over acquiring high-cost, zero-defect visualization tools, leading to lengthened sales cycles and postponed deployment strategies.

This financial hesitation is directly correlated with market contraction across the wider automation landscape. As reported by VDMA Robotics + Automation in June 2025, the broader German automation industry was projected to suffer a 10 percent revenue decline for the year due to postponed investment plans and geopolitical tensions. This statistical downturn illustrates how economic instability forces end-users to freeze capital expenditures, thereby stalling the momentum of advanced imaging technologies despite their technical superiority. Consequently, the inability to justify immediate returns on these expensive investments remains a primary obstacle hampering broader market penetration.

Market Trends

The transition toward sustainable and helium-free MRI architectures is reshaping the market by addressing supply chain vulnerabilities associated with liquid helium reliance. Conventional scanners require thousands of liters of coolant, exposing providers to volatile commodity prices and quench hazards that necessitate expensive venting infrastructure. By adopting sealed, low-helium magnet technology, facilities eliminate these logistical burdens while enabling installation in previously inaccessible locations due to reduced system weight. Validating this industry shift toward operationally resilient infrastructure, Philips reported in a November 2024 press release regarding its next-generation BlueSeal helium-free MRI system that its technology has conserved nearly 2.75 million liters of liquid helium to date.

The commercialization of Photon-Counting Computed Tomography Systems represents a hardware evolution from scintillator-based detectors to direct-conversion sensors. This architecture registers individual X-ray photons to provide intrinsic spectral data, significantly reducing electronic noise and enabling the visualization of minute structures with high clarity. Unlike traditional energy-integrating detectors, these platforms facilitate precise material decomposition and lower radiation dosages for vulnerable patient populations. Underscoring the clinical integration of this advanced modality, Siemens Healthineers confirmed in a December 2024 press release expanding its Photon-Counting CT portfolio that over one million patients worldwide have been scanned using their photon-counting technology.

Key Market Players

  • Siemens Healthineers AG
  • GE HealthCare Technologies Inc.
  • Philips Healthcare
  • Canon Medical Systems Corporation
  • Fujifilm Holdings Corporation
  • Sony Corporation
  • Qualcomm Technologies, Inc.
  • Olympus Corporation
  • Karl Storz SE & Co. KG
  • Nanox.vision Ltd.

Report Scope

In this report, the Global Next Imaging Technology Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Next Imaging Technology Market, By Technique

  • Optical
  • Radiography
  • Thermal
  • Scanning

Next Imaging Technology Market, By Application

  • Medical
  • Automotive
  • Surveillances
  • Civil engineering

Next Imaging Technology Market, By Type

  • Electromagnetic Imaging
  • CMOS Imaging

Next Imaging Technology Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Next Imaging Technology Market.

Available Customizations:

Global Next Imaging Technology Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Next Imaging Technology Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Technique (Optical, Radiography, Thermal, Scanning)
    • 5.2.2. By Application (Medical, Automotive, Surveillances, Civil engineering)
    • 5.2.3. By Type (Electromagnetic Imaging, CMOS Imaging)
    • 5.2.4. By Region
    • 5.2.5. By Company (2025)
  • 5.3. Market Map

6. North America Next Imaging Technology Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Technique
    • 6.2.2. By Application
    • 6.2.3. By Type
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Next Imaging Technology Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Technique
        • 6.3.1.2.2. By Application
        • 6.3.1.2.3. By Type
    • 6.3.2. Canada Next Imaging Technology Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Technique
        • 6.3.2.2.2. By Application
        • 6.3.2.2.3. By Type
    • 6.3.3. Mexico Next Imaging Technology Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Technique
        • 6.3.3.2.2. By Application
        • 6.3.3.2.3. By Type

7. Europe Next Imaging Technology Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Technique
    • 7.2.2. By Application
    • 7.2.3. By Type
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Next Imaging Technology Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Technique
        • 7.3.1.2.2. By Application
        • 7.3.1.2.3. By Type
    • 7.3.2. France Next Imaging Technology Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Technique
        • 7.3.2.2.2. By Application
        • 7.3.2.2.3. By Type
    • 7.3.3. United Kingdom Next Imaging Technology Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Technique
        • 7.3.3.2.2. By Application
        • 7.3.3.2.3. By Type
    • 7.3.4. Italy Next Imaging Technology Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Technique
        • 7.3.4.2.2. By Application
        • 7.3.4.2.3. By Type
    • 7.3.5. Spain Next Imaging Technology Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Technique
        • 7.3.5.2.2. By Application
        • 7.3.5.2.3. By Type

8. Asia Pacific Next Imaging Technology Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Technique
    • 8.2.2. By Application
    • 8.2.3. By Type
    • 8.2.4. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Next Imaging Technology Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Technique
        • 8.3.1.2.2. By Application
        • 8.3.1.2.3. By Type
    • 8.3.2. India Next Imaging Technology Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Technique
        • 8.3.2.2.2. By Application
        • 8.3.2.2.3. By Type
    • 8.3.3. Japan Next Imaging Technology Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Technique
        • 8.3.3.2.2. By Application
        • 8.3.3.2.3. By Type
    • 8.3.4. South Korea Next Imaging Technology Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Technique
        • 8.3.4.2.2. By Application
        • 8.3.4.2.3. By Type
    • 8.3.5. Australia Next Imaging Technology Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Technique
        • 8.3.5.2.2. By Application
        • 8.3.5.2.3. By Type

9. Middle East & Africa Next Imaging Technology Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Technique
    • 9.2.2. By Application
    • 9.2.3. By Type
    • 9.2.4. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Next Imaging Technology Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Technique
        • 9.3.1.2.2. By Application
        • 9.3.1.2.3. By Type
    • 9.3.2. UAE Next Imaging Technology Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Technique
        • 9.3.2.2.2. By Application
        • 9.3.2.2.3. By Type
    • 9.3.3. South Africa Next Imaging Technology Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Technique
        • 9.3.3.2.2. By Application
        • 9.3.3.2.3. By Type

10. South America Next Imaging Technology Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Technique
    • 10.2.2. By Application
    • 10.2.3. By Type
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Next Imaging Technology Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Technique
        • 10.3.1.2.2. By Application
        • 10.3.1.2.3. By Type
    • 10.3.2. Colombia Next Imaging Technology Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Technique
        • 10.3.2.2.2. By Application
        • 10.3.2.2.3. By Type
    • 10.3.3. Argentina Next Imaging Technology Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Technique
        • 10.3.3.2.2. By Application
        • 10.3.3.2.3. By Type

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Next Imaging Technology Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Siemens Healthineers AG
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. GE HealthCare Technologies Inc.
  • 15.3. Philips Healthcare
  • 15.4. Canon Medical Systems Corporation
  • 15.5. Fujifilm Holdings Corporation
  • 15.6. Sony Corporation
  • 15.7. Qualcomm Technologies, Inc.
  • 15.8. Olympus Corporation
  • 15.9. Karl Storz SE & Co. KG
  • 15.10. Nanox.vision Ltd.

16. Strategic Recommendations

17. About Us & Disclaimer